Skip to main content
. 2021 Jan 29;2021(1):CD013496. doi: 10.1002/14651858.CD013496.pub2

NCT03539094.

Study name Intermittent Fasting in Multiple Sclerosis (IFMS)
Methods Randomised controlled trial
Participants 60 participants
Ages Eligible for Study: 18 years and older (adult, older adult)
Sexes Eligible for Study: all
Accepts Healthy volunteers: no

Inclusion Criteria
Diagnosis of RRMS (2010 Mc Donald criteria)
EDSS <6.0 and disease duration ≤ 15 years
On an injectable therapy for MS, glatiramer acetate (GA) or beta‐interferon (beta‐IFN) for at least 3 months prior to the study and with no anticipated changes of the medication for the 12‐week study duration
Age ≥18 years
BMI > 22 and < 35 kg/m2 with stable weight in the 3 months prior to screening
Interventions Arm Intervention/treatment
Experimental: Intermittent fasting
The participants randomised to this group will do IF by restricting their diet and consuming few calories two days per week. During the days of fasting, participants will be allowed to drink water, calorie‐free beverages, and eat fresh, steamed or roasted non‐starchy vegetables.
Other: intermittent fasting
the participants randomised to this group will do IF by restricting their diet and consuming few calories two days per week. During the days of fasting, subjects will be allowed to drink water, calorie‐free beverages, and eat fresh, steamed or roasted non‐starchy vegetables.
No Intervention: Western diet
The participants randomised to this group will eat a standard Western style diet.
Outcomes Primary Outcome Measures
Leptin [ Time Frame: 12 weeks ]
Leptin at week 12 measured in the peripheral blood
Secondary Outcome Measures
Peripheral metabolic and inflammatory profiling [ Time Frame: 12 weeks ]
Adipokine and inflammatory markers at week 12 measured in the peripheral blood
Anthropometric measure [ Time Frame: 12 weeks ]
Weight and height will be combined to report BMI in kg/mg^2
Anthropometric measure [ Time Frame: 12 weeks ]
Waist circumference in cm
Gut microbiota [ Time Frame: 12 weeks ]
Gut microbiota richness and composition
Starting date January 1, 2018
Contact information picciol@neuro.wustl.edu
Notes NCT03539094